Basel, Switzerland Genedata, a leading provider of advanced software solutions for life science research and development, and Bayer, today announced the extension of their long-term partnership. Genedata supports Bayer’s Crop Science division to digitalize R&D processes and this extended partnership now includes a license to the Genedata Selector® platform to support Bayer’s global discovery process and data […]
MINNEAPOLIS — Bio-Techne, a global leader of research and manufacturing-grade reagents, has announced a corporate initiative to advance cell and gene therapy research and ex vivo cell processing. Through strategic acquisitions and internal scientific innovation, Bio-Techne has become uniquely positioned to provide a comprehensive, innovative, and flexible set of reagents and instrumentation across the cell and gene […]
Phase II grant to support development of innovative exosome characterization platform BOSTON — NanoView Biosciences, an emerging leader in the field of exosome characterization, has been awarded a National Science Foundation Small Business Innovation Research Phase II grant in the amount of $750,000. The program will focus on completing development of the ExoView™ system, the company’s innovative instrument and […]
Global investment firm backs growth plans for TTP Labtech Cambridge, UK: TTP Labtech Ltd, an international leader in the design and development of automated instrumentation and consumables for life science research is pleased to announce that investment from Battery Ventures has underpinned their aggressive growth plans. Over the last 18 years TTP Labtech has successfully […]
New enterprise brings together cutting-edge technologies in Genetic Testing from Ambry, Konica Minolta’s Imaging, and AI-technology from Invicro, to fight diseases including cancer and Alzheimer’s Offering fully-fledged precision medicine services to pharmaceutical companies, academia and medical institutions/hospitals in Japan Tokyo – Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902; ISIN: JP3300600008) today announced the launch of […]
On September 26, 2018, BGI and Maxwell Plus executed a collaborative research project “A model to predict the risk of developing advanced or metastatic prostate cancer using genetic makeup and family history of cancers”. Prostate cancer is the second most common type of cancer among males in Western countries, with an estimated 165,000 new cases and 29,500 […]
Livingston, N.J., Munich, Germany, September 26, 2018: Nanion announced today that Charles River Laboratories has purchased two SyncroPatch 384PE high-throughput patch clamp instruments. This purchase reflects an investment in screening technologies and assay development, while accommodating the rising demand in contract service for globally shared clients. The instruments willbe delivered to Charles River (Cleveland site; […]
Worldwide Success of Company’s Aurora Flow Cytometry Systems Accelerates Momentum The Cytek Aurora delivers on Cytek’s promise to make high-quality flow cytometry accessible to a larger number of researchers and clinicians. The Series C funding round will facilitate the expansion of Cytek’s footprint around the world. FREMONT, Calif. — Cytek Biosciences Inc., the preeminent provider of […]
STONY BROOK N.Y. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) announced today that it is launching an additional system to tag the industry’s larger volume cannabis or hemp grows as part of TheraCann International’s ETCH Biotrace™ solution. On the heels of its successful showing of its first Cannabis Tagging System (CTS) in July […]
VANCOUVER, BRITISH COLUMBIA – STEMCELL Technologies has today announced that they have signed an exclusive license agreement with Brigham and Women’s Hospital for rights to commercialize technologies for the generation of human pluripotent stem cell-derived kidney organoids. This innovative technology, developed by Drs. Benjamin S. Freedman when he was at Brigham and Women’s Hospital and Joseph V. […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
